Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dum

Showing results (131-140 of 202) with videos related to

Pageof 21
Sort By:
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
Expert Review of Molecular Diagnostics|July 22, 2022
Villin expression in human tumors: a tissue microarray study on 14,398 tumorsDavid Dum, Maximilian Lennartz, Anne Menz, et al.
Experimental and Molecular Pathology|April 7, 2022
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancersDavid Dum, Anne Menz, Cosima Völkel, et al.
Biomed Research International|November 16, 2020
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical RecurrenceSimon Kind, Martina Kluth, Claudia Hube-Magg, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 17, 2023
GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 TumorsViktor Reiswich, Carol E Schmidt, Maximilian Lennartz, et al.
Molecular and Cellular Endocrinology|November 11, 2023
Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumorsKatharina Möller, Ria Uhlig, Natalia Gorbokon, et al.
World Journal of Urology|November 21, 2019
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancerSimon Kind, Franziska Büscheck, Doris Höflmayer, et al.
Biomedicines|October 27, 2022
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 TumorsSören Weidemann, Nessar Ahmad Noori, Maximilian Lennartz, et al.
Virchows Archiv : an International Journal of Pathology|September 24, 2021
Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implicationsCosima Völkel, Noémi De Wispelaere, Sören Weidemann, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Pageof 21

Showing results (131-140 of 202) with videos related to

Sort By:
Pageof 21
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
Expert Review of Molecular Diagnostics|July 22, 2022
Villin expression in human tumors: a tissue microarray study on 14,398 tumorsDavid Dum, Maximilian Lennartz, Anne Menz, et al.
Experimental and Molecular Pathology|April 7, 2022
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancersDavid Dum, Anne Menz, Cosima Völkel, et al.
Biomed Research International|November 16, 2020
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical RecurrenceSimon Kind, Martina Kluth, Claudia Hube-Magg, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 17, 2023
GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 TumorsViktor Reiswich, Carol E Schmidt, Maximilian Lennartz, et al.
Molecular and Cellular Endocrinology|November 11, 2023
Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumorsKatharina Möller, Ria Uhlig, Natalia Gorbokon, et al.
World Journal of Urology|November 21, 2019
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancerSimon Kind, Franziska Büscheck, Doris Höflmayer, et al.
Biomedicines|October 27, 2022
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 TumorsSören Weidemann, Nessar Ahmad Noori, Maximilian Lennartz, et al.
Virchows Archiv : an International Journal of Pathology|September 24, 2021
Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implicationsCosima Völkel, Noémi De Wispelaere, Sören Weidemann, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Pageof 21